IRIS
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.460
AS - Asia 3.494
EU - Europa 3.094
SA - Sud America 390
AF - Africa 54
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 9
Totale 11.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.338
CN - Cina 2.055
IE - Irlanda 798
SG - Singapore 727
HK - Hong Kong 393
UA - Ucraina 386
IT - Italia 373
RU - Federazione Russa 363
FI - Finlandia 353
DE - Germania 351
BR - Brasile 308
GB - Regno Unito 153
VN - Vietnam 134
SE - Svezia 107
CA - Canada 85
FR - Francia 64
IN - India 38
AR - Argentina 35
BE - Belgio 34
BD - Bangladesh 30
JP - Giappone 28
MX - Messico 24
PL - Polonia 23
AT - Austria 20
ZA - Sudafrica 19
AU - Australia 17
EC - Ecuador 16
NL - Olanda 14
NZ - Nuova Zelanda 12
ES - Italia 11
CO - Colombia 10
IQ - Iraq 10
KE - Kenya 10
MA - Marocco 10
TR - Turchia 8
PK - Pakistan 7
CH - Svizzera 6
CL - Cile 6
EU - Europa 6
IR - Iran 6
JO - Giordania 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
ID - Indonesia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
KG - Kirghizistan 4
KR - Corea 4
LT - Lituania 4
LU - Lussemburgo 4
PE - Perù 4
SA - Arabia Saudita 4
AL - Albania 3
AZ - Azerbaigian 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
KZ - Kazakistan 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
DZ - Algeria 2
ET - Etiopia 2
LV - Lettonia 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
QA - Qatar 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
TH - Thailandia 1
TJ - Tagikistan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 11.530
Salva come PNG Salva come JPEG
Città #
Dublin 795
Chandler 708
Jacksonville 493
Nanjing 436
Hong Kong 389
Beijing 381
Ashburn 370
Dallas 368
Singapore 330
Boardman 199
Nanchang 171
Wilmington 145
Princeton 140
Lawrence 138
Shenyang 135
Changsha 121
Helsinki 120
Hebei 119
Ann Arbor 118
Los Angeles 112
Jiaxing 108
Medford 97
Milan 94
New York 83
Hangzhou 71
Pavia 66
Shanghai 66
Tianjin 63
Redondo Beach 61
Moscow 59
Buffalo 53
Ho Chi Minh City 51
Munich 49
Toronto 43
Woodbridge 36
São Paulo 32
Brussels 29
Tokyo 28
Norwalk 27
Seattle 27
Houston 25
Falkenstein 23
Verona 23
Hanoi 22
Fairfield 21
Nuremberg 21
Turku 21
Warsaw 20
Brooklyn 19
Ottawa 19
Frankfurt am Main 18
Zhengzhou 18
Denver 16
Johannesburg 16
Kunming 16
Chicago 15
San Francisco 15
Falls Church 14
The Dalles 14
Boston 13
Guangzhou 13
Trieste 13
Bergamo 12
Des Moines 12
Stockholm 12
Atlanta 11
Florence 11
Jinan 11
London 11
Montreal 11
Pune 11
Columbus 10
Santa Clara 10
Chennai 9
Manchester 9
Nairobi 9
Phoenix 9
Poplar 9
Belo Horizonte 8
Berlin 8
Piscataway 8
Rochester 8
Secaucus 8
Brasília 7
Orange 7
Orem 7
Vienna 7
Amman 6
Amsterdam 6
Auburn Hills 6
Brisbane 6
Liverpool 6
Lodi 6
Mexico City 6
Modena 6
Quito 6
Sydney 6
Travaco Siccomario 6
Washington 6
Antwerp 5
Totale 7.638
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 276
A first update on mapping the human genetic architecture of COVID-19 164
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 138
Gene symbol: KCNH2 127
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 126
Long QT and short QT syndromes. 126
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 122
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 121
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 118
FGF12 is a candidate Brugada syndrome locus. 115
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 114
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 110
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 106
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 106
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 103
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 102
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 102
Long QT syndrome-associated mutations in intrauterine fetal death. 102
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 101
QT lungo, sindrome del 100
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 100
Inherited cardiac arrhythmia syndrome. Role of potassium channels 99
Cardiac potassium channel dysfunction in sudden infant death syndrome. 99
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 98
All LQT3 patients need an ICD. True or false? 97
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 97
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 97
Cardiac sodium channel dysfunction in sudden infant death syndrome. 95
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 95
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 94
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 93
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 93
Can a message from the dead save lives? 92
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 92
The ICD for the long QT syndrome: which indications, complications, and results? 91
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 91
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 90
Prevalence of the congenital long-QT syndrome. 90
The genetics underlying acquired long QT syndrome: impact for genetic screening. 90
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 89
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 88
Brugada and Long QT Syndrome are two different diseases: True or False? 88
Congenital long QT and short QT syndromes 88
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 88
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 87
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 86
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 86
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 85
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 85
Idiopathic Ventricular Fibrillation. 83
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 83
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 83
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 83
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 82
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 82
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 82
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 82
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 81
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 81
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 81
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 80
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 80
QTc behavior during exercise and genetic testing for the long-QT syndrome. 79
Gene symbol: KCNH2 79
Clinical implications for patients with Long QT Syndrome who experience a cardiac event during infancy 79
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 79
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 78
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 78
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 78
Gene symbol: SCN5A 77
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 77
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 77
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 76
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 76
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 75
The Long QT Syndrome 73
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 73
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 73
Gene symbol: KCNH2. 72
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 72
Gene symbol: KCNH2. 72
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 72
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 71
Gene expression and arrhythmic risk. 71
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 71
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 71
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 71
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients. 71
Calmodulin mutations associated with recurrent cardiac arrest in infants. 71
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 71
Gene symbol: KCNH2 70
Congenital long QT and short QT syndromes 69
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. 69
Ion channel diseases in children: manifestations and management. 69
Sindrome di Brugada 68
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 68
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. 68
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. 67
Gene symbol: KCNQ1 67
Gene symbol: SCN5A. 67
Totale 8.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 91 7 138 20 99 88 13
2021/2022577 13 5 33 7 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024820 92 136 22 53 73 196 23 77 5 30 65 48
2024/20252.079 45 178 62 51 46 116 103 174 526 74 220 484
2025/20262.517 376 391 519 429 622 180 0 0 0 0 0 0
Totale 11.703